Download Citation
Article Source:
Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study
Szabo SM,
Hirji I,
Johnston KM,
Juarez-Garcia A,
Connors JM
(2017)
Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study.
PLOS ONE 12(10): e0180261.
https://doi.org/10.1371/journal.pone.0180261